Sexual health access at retail pharmacies for young women
Part of Digestive system, Immune system & allergy, Infections clinical trials.
This trial tests whether offering HIV prevention (PrEP) and STI prevention at retail pharmacies helps young women access these services. It focuses on women who are already visiting a pharmacy for birth control.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are a cisgender woman (assigned female at birth and identify as a woman).
- You are between 15 and 25 years old.
- You are at the pharmacy to get birth control (like the pill, shot, implant, condoms, or emergency contraception).
- You are willing to take an HIV test and consider taking PrEP (a daily pill to prevent HIV).
- You are not currently taking PrEP.
- You plan to live in the area for the next 12 months.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study helps healthcare providers and clinics deliver long-acting injectable PrEP (a preventive HIV medication given as an injection) more effectively. Researchers will study how clinics can better implement and offer this option to patients who need it.
This study offers a way for adolescent girls and young women in Tanzania to get PrEP (a daily pill that helps prevent HIV) from local pharmacies instead of only from clinics. It aims to make starting and staying on PrEP easier and more convenient.
This study helps connect young people aged 13–24 to PrEP, a daily pill that prevents HIV. It tests whether offering PrEP in clinics or community locations makes it easier for you to get and stay on this prevention medication.
This trial studies whether giving the antibiotic doxycycline right after sex (known as Doxy-PEP) can prevent STIs. It asks participants to provide hair, blood, and urine samples and follow specific guidelines about hair and condom use.
This study tests whether pharmacies can safely provide HIV prevention medications (PrEP for prevention, PEP for emergency treatment) and HIV testing through phone or video visits. It aims to make these services easier to access without visiting a hospital or clinic.
This study tests a program to help adolescent girls and young women at high risk of HIV take PrEP consistently. It aims to improve access and adherence to PrEP, a daily pill that prevents HIV.
Hear when a new Sexually Transmitted Infections (Not HIV or Hepatitis) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.